MARY MCKEE: Open Payments
NPI 1649676636 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,973 in 165 payments from 19 companies in 2025. Trend: 2023 $902 · 2024 $1,293 · 2025 $2,973
Food & beverage: $2,873Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 19 | $400 |
| Arcutis Biotherapeutics, Inc. | 27 | $375 |
| ABBVIE INC. | 30 | $360 |
| Janssen Biotech, Inc. | 17 | $334 |
| Incyte Corporation | 15 | $291 |
| Galderma Laboratories, L.P. | 10 | $229 |
| GENZYME CORPORATION | 9 | $227 |
| Lilly USA, LLC | 9 | $181 |
| LEO Pharma Inc. | 7 | $143 |
| UCB, Inc. | 3 | $78 |
Products named: DUPIXENT, Zoryve, TREMFYA, SKYRIZI, OPZELURA, NEMLUVIO, TALTZ, ADBRY.
Industry payments across TX — which companies pay providers there.
